Skin Dryness

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Skin Dryness trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 36 trials

RecruitingNot Applicable

NCT02327884

Characterization of Diseases With Salivary Gland Involvement

Background: \- Salivary glands in and around the mouth and throat make saliva. Salivary gland disorders can affect a person s quality of life. Studying people…

United States1,150 participantsStarted 2015-04-03

RecruitingNot Applicable

NCT03003572

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

Primary Sjögren's syndrome (pSS) can affect various organs, sometimes leads to life-threatening conditions and is always responsible for a decreased quality of…

France185 participantsStarted 2018-03-27

Treatment: Blood samples

RecruitingPhase 3

NCT07404865

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

United States250 participantsStarted 2026-02-26

Treatment: Telitacicept, Placebo

RecruitingNot Applicable

NCT07014007

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

Pierre Fabre Laboratories have developed a cream with medical device status, RV4421B-EV0407 indicated for the treatment of eczemas, including atopic eczema, con…

Mauritius105 participantsStarted 2025-09-30

Treatment: RV4421B- EV0407

RecruitingPhase 3

NCT05379153

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

This phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be com…

United States250 participantsStarted 2026-04-21

Treatment: Laser Therapy, Sham Intervention

RecruitingPhase 3

NCT06747949

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.

United States844 participantsStarted 2025-02-25

Treatment: Dazodalibep

All recent trials (100 shown)

Active — Not RecruitingPhase 3

NCT06741969

Nipocalimab in Moderate to Severe Sjogren's Disease

The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (SjD).

United States655 participantsStarted 2024-12-04

Treatment: Nipocalimab, Placebo

TerminatedPhase 2

NCT06312020

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS).

United States209 participantsStarted 2024-05-09

Treatment: HZN-1116, Placebo

Skin Dryness

Trial phase breakdown

Trial status

Actively recruiting — 36 trials

Characterization of Diseases With Salivary Gland Involvement

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

All recent trials (100 shown)

Nipocalimab in Moderate to Severe Sjogren's Disease

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 36 trials

Characterization of Diseases With Salivary Gland Involvement

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

All recent trials (100 shown)

Nipocalimab in Moderate to Severe Sjogren's Disease

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque…

Wheat-free Diet in the Treatment of Sjogren's Syndrome

Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safe…

Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel

Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Re…

Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin

Human In Use Test of GINHI-HP-009 in Healthy Adults

Human In Use Test of GINPI-HP-004 in Healthy Adults

Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women

A Study of BEN301 Injection in theTreatment of Autoimmune Diseases

Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Pregnancy and Medically Assisted Conception in Rare Diseases

Auto-immunity and Pulmonary Arterial Hypertension

A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome